-Resultados del estudio clínico de fase I del anticuerpo bifuncional PD-1/CTLA-4 Iparomlimab/Tuvonralimab de Qilu Pharma publicado en línea en Journal of Hematology & Oncology JINAN, China, 12 de mayo de 2023 /PRNewswire/ — El 8 de mayo de 2023, Journal of Hematology & Oncology (JHO, 2022 factor de impacto de 23.168) publicó los resultados del … Read more
CHICAGO , May 12, 2023 /PRNewswire/ — MarketsandMarkets Conferences is a leading organizer of global conferences and events in the fields of Pharma, Healthcare, and Life Sciences. We are delighted to announce our forthcoming Infectious Disease and Molecular Diagnostics Conference, which is scheduled to take place in Boston, USA, on 19th-20th October 2023. The event will … Read more
David A. Marcantel, MD, FACOG, Medical Director All procedures are carried out using the Empower RF or Optimas system, machines encompassing a suite of technologies all in one place. In most cases, non-invasive and minimally invasive treatments for tightening or rejuvenation are pain-free, resulting in an enhanced patient experience through better overall results from a single treatment session. For additional information on InMode aesthetics … Read more
DURHAM, N.C., May 12, 2023 /PRNewswire/ — Gestational diabetes, prenatal depression, and postpartum depression were each individually associated with higher levels of early childhood behavior problems such as attentional problems, anxiety, and depression in new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health. Previous research has … Read more
DUBLIN, May 12, 2023 /PRNewswire/ — The “Global Acute Bacterial Skin and Skin Structure Infections Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global acute bacterial skin and skin structure infections (ABSSSI) treatment market size was valued at USD 9.5 billion in 2022 and is projected to grow at a … Read more
SALT LAKE CITY, May 12, 2023 /PRNewswire/ — Novarad’s VisAR, a surgical navigation system that uses augmented reality, has received clearance from Indonesia’s FDA for intraoperative use in stereotactic spinal surgery. VisAR is accurate for both open and minimally invasive surgery (MISS). This cutting-edge technology enables surgeons to transform a patient’s imaging data into a … Read more
GARDNER, Mass., May 12, 2023 /PRNewswire/ — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of a follow-on product development order for a next generation single-use urology program totaling approximately $1.5 million from an established medical device company … Read more
Findings to be presented at International Association of Parkinsonism and Related Disorders (IARPD) 2023 World Congress being held May 13-16, 2023. BEDMINSTER, N.J., May 12, 2023 /PRNewswire/ — Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, will share results from a retrospective study evaluating … Read more
The global amyotrophic lateral sclerosis treatment market is driven by factors such as an increase in prevalence of amyotrophic lateral sclerosis, initiatives by government and non-government organizations, and growth in awareness and understanding of ALS. PORTLAND, Ore., May 12, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Amyotrophic Lateral Sclerosis Treatment Market by … Read more
BEDFORD, Mass., May 12, 2023 /PRNewswire/ — Sealonix announced today that it has closed a $20 million Series A financing. The round was led by Excelestar Ventures with additional participation from AMED Ventures, Sparta Group, Iyengar Capital, J2 Ventures and TiE Boston. Sealonix is using its biomaterials expertise to develop next generation hemostatic sealants for … Read more